New Delhi, Feb 7 (IANS) Health industry leaders on Saturday welcomed the interim agreement on the bilateral trade deal between India and the US.As part of the interim framework, the US will slash reciprocal tariffs on Indian goods to 18 per cent. The US will also remove the reciprocal tariff on generic pharmaceuticals, among other sectors like gems and diamonds, and aircraft parts. Although full details are yet to emerge, the interim India-US trade deal framework indicates that India has receive…
Latest AiMeD News & Updates
New Delhi, Feb 3 (IANS) The trade deal between India and the US is a game-changer for the Indian MedTech and pharma sectors, said industry experts on Tuesday.In a historic move, the US has announced a reduction in tariffs on Indian exports to 18 per cent from 50 per cent, which is a constructive development for the India-US trade relations.The US is India’s largest export destination, accounting for about 20 per cent of total exports.The Association of Indian Medical Devices (AiMeD), hailed th…
New Delhi, Feb 1 (IANS) Industry experts on Sunday hailed the Union Budget 2026’s push to the biopharma sector, clinical trials, along with its thrust to the medical tourism and Ayurveda.The Union Budget 2026-27, presented by Finance Minister Nirmala Sitharaman in Parliament, proposed the Biopharma Shakti (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) scheme.The scheme, with an outlay of Rs 10,000 crores over the next five years, aims to develop India as a …
New Delhi, Jan 27 (IANS) The historic trade deal between India and the European Union will boost access to medicines as well as create more opportunities, said industry experts on Tuesday.Prime Minister Narendra Modi and European Commission President Ursula von der Leyen jointly announced the conclusion of the “mother of all deals”, marking a historic milestone in India-EU economic relations and trade engagement with key global partners.As per the FTA, tariffs on 90 per cent of European optical,…